Letter to the editor: reply to Bousman et al

Graeme K Suthers; Tom M Polasek

doi:10.2217/pgs-2019-0110

Letter to the editor: reply to Bousman et al

Pharmacogenomics. 2019 Oct;20(15):1061-1062. doi: 10.2217/pgs-2019-0110.

Authors

Graeme K Suthers¹, Tom M Polasek^{2

3

4}

Affiliations

¹ Sonic Healthcare (Australia), 14 Giffnock Ave, Macquarie Park NSW, Australia.
² Royal Adelaide Hospital, Port Road, Adelaide, SA 5000, Australia.
³ Centre for Medicines Use and Safety, Monash University, Parkville, VIC, Australia.
⁴ Certara, Princeton, NJ 08540, USA.

PMID: 31588874
DOI: 10.2217/pgs-2019-0110

Abstract

Letter regarding: Bousman CA, Arandjelovic K, Mancuso SG, Eyre HA, Dunlop BW. Pharmacogenetic tests and depressive symptom remission: a meta-analysis of randomized controlled trials. Pharmacogenomics 20(1), 37-47 (2019).

Keywords: cohort-level; individual-level; meta-analyses; patient-specific relative risk of remission; pharmacogenetic-informed prescribing; pooled relative risk of remission; randomized control trials.

Publication types

Letter
Comment

MeSH terms

Depression*
Pharmacogenetics*
Randomized Controlled Trials as Topic